Press Releases

BrightFocus Foundation’s 2022 annual report highlights an incredible year of pioneering neurodegenerative research.  

BrightFocus Foundation yesterday presented its first-ever Alzheimer’s Disease Research (ADR) named awards to two leading researchers in recognition of their innovative work to prevent, treat, and, ultimately, cure Alzheimer’s disease.

The newly expanded accessible audio program will connect patients with vision experts and provide the latest glaucoma research news.

Findings are the first to show a statistically significant decrease in cognitive decline by an anti-amyloid drug.

The impact factor of Molecular Neurodegeneration, the official scientific journal of BrightFocus Foundation, has risen to 18.879, according to its publisher, up from 14.195 a year ago.

BrightFocus Foundation’s Alzheimer’s Disease Research program announced a request for scientific proposals for promising research on Alzheimer’s disease and related dementias. The application deadline is November 1, 2022, for projects beginning in 2023.

BrightFocus Foundation, a leading nonprofit funder of vision research, has announced a request for proposals for scientific projects supported through its National Glaucoma Research (NGR) program. The application deadline is October 25, 2022, for projects beginning in 2023.

Eric McCormack, actor, singer, will perform a musical tribute to the legendary Gene Wilder following a documentary sneak preview of WILDER: His Life, Legacy and Battle with Alzheimer’s Disease at awards gala supporting research for diseases of mind and sight.

BrightFocus Foundation, a premier private funder of vision research, today announced a request for proposals for projects supported through its Macular Degeneration Research program.

Free Educational Program Will Offer Expert Insight On Age-Related Macular Degeneration Condition